The key results of this study show a possibly lower risk of aPL positivity in both patients with overweight (BMI 25-30) and patients with obesity (BMI> 30) when compared to patients with BMI<25, though this was not statistically significant. This evidence concerns the gene FASLG and obesity due to melanocortin 4 receptor deficiency.